Both compounds are administered via weekly subcutaneous injection
The development of patient assistance programs and structured payment options is improving treatment affordability for middle-income populations
Empirical Health's heart health panel tracks ApoB, hs-CRP, glucose, kidney, liver, and nutrition markers over time, so you and your doctor can see what the drug is actually doing
Weight loss of 510% of initial body weightcommonly achieved with Saxendais associated with meaningful reductions in both systolic and diastolic blood pressure
Key Takeaways Retatrutide harnesses a triple-hormone approach to target metabolic function, potentially combating menopause weight gain and enhancing metabolic health
Pantanetti P, Cangelosi G, Alberti S, Di Marco S, Michetti G, Cerasoli G, et al